Getting Down to Business

Is there a genetic component to entrepreneurial success?

Written byKerry Grens
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ANDRZEJ KRAUZEScott Shane, an economist at Case Western Reserve University who has been teaching entrepreneurship for 20 years, has heard it all when it comes to his undergraduates pitching ideas for new businesses. Some students put in extensive time and research to come up with a business proposal that flops when they try to express it as a convincing pitch. Others put in no effort and wing it after glancing over some information, but come up with a marvelous proposal. “It’s like an intuitive sense,” Shane says, “like they could see what the marketplace would want.”

In Shane’s field, business phenoms who so effortlessly produce innovative ideas and succeed at starting businesses are often referred to as “born entrepreneurs.” For years, Shane’s been interested in whether science could corroborate such a genetic endowment. So in 2008, he turned to a UK registry of several thousand twins to find out. Looking at eight measures related to entrepreneurship, such as the number of years self-employed and the number of businesses owned, Shane calculated that entrepreneurship was between 30 and 55 percent heritable (Management Science, 54:167-79, 2008). “That’s not trivial,” he says.

A year later, Zhen Zhang, now a management professor at Arizona State University, followed up with another twin study, but added a twist. Zhang looked at the sex of the participants from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies